The combined dexamethasone-suppression/CRH-stimulation test in alcoholics during and after acute withdrawal.
about
The Historical Development of Immunoendocrine Concepts of Psychiatric Disorders and Their TherapyNo association of CRH1 receptor polymorphism haplotypes, harm avoidance and other personality dimensions in alcohol dependence: results from the Munich gene bank project for alcoholism.Tolerability of the dexamethasone-corticotropin releasing hormone test in major depressive disorder.Hypothalamic-pituitary-adrenal axis modulation of GABAergic neuroactive steroids influences ethanol sensitivity and drinking behaviorEffect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine study.Positive environmental modification of depressive phenotype and abnormal hypothalamic-pituitary-adrenal axis activity in female C57BL/6J mice during abstinence from chronic ethanol consumptionFunctional CRH variation increases stress-induced alcohol consumption in primates.Focus on: Comorbid mental health disordersCorticotropin-releasing factor testing reveals a dose-dependent difference in methadone maintained vs control subjects.Early experience and sex interact to influence limbic-hypothalamic-pituitary-adrenal-axis function after acute alcohol administration in rhesus macaques (Macaca mulatta).Corticotropin Releasing Factor in the Bed Nucleus of the Stria Terminalis in Socially Defeated and Non-stressed Mice with a History of Chronic Alcohol Intake.Adrenocorticotropic hormone/cortisol response to physical exercise in abstinent alcoholic patients.Cortisol concentrations, stress-coping styles after withdrawal and long-term abstinence in alcohol dependence.Involvement of activated brain stress responsive systems in excessive and "relapse" alcohol drinking in rodent models: implications for therapeutics.
P2860
Q26774472-33418B60-A4DE-4EC6-97DA-512E94C90691Q33448235-FD886E64-6DAB-44F9-A111-DBDB47680CFEQ34180109-A83101E3-E748-4AB4-A0B5-620400894BC3Q35236873-6B03A91A-CAC4-4AB6-9CB7-5AB0C370A4ABQ36641425-F585940F-D465-4700-9ED2-0BD4AD5FDC8AQ37043447-E4C54F8B-53AA-4028-835A-6A0A4431AB1BQ37321242-FED7447B-D200-4A98-8F47-4BF3346E337EQ37460548-56C9A4DF-A8BC-454D-8E2D-B3E013F080ABQ44407172-F0DF4654-187C-47EE-A24B-984BC5ED0813Q44977125-B108D64A-1B60-4F22-9AB7-B4140A229F25Q46506794-DECCEFB3-37E7-4ACC-8CBD-B16DF1F6BBAAQ48228343-F81F0BB7-AF19-44F4-8E83-F0175CCB0A78Q48487439-3EBA8262-3C72-4DA4-8DB1-EDAC3E66195CQ52317998-F290508A-7381-4D0D-A602-5ABBFABA83A1
P2860
The combined dexamethasone-suppression/CRH-stimulation test in alcoholics during and after acute withdrawal.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
The combined dexamethasone-sup ...... ng and after acute withdrawal.
@en
The combined dexamethasone-sup ...... ng and after acute withdrawal.
@nl
type
label
The combined dexamethasone-sup ...... ng and after acute withdrawal.
@en
The combined dexamethasone-sup ...... ng and after acute withdrawal.
@nl
prefLabel
The combined dexamethasone-sup ...... ng and after acute withdrawal.
@en
The combined dexamethasone-sup ...... ng and after acute withdrawal.
@nl
P2093
P2860
P1476
The combined dexamethasone-sup ...... ng and after acute withdrawal.
@en
P2093
P2860
P304
P356
10.1111/J.1530-0277.2001.TB02268.X
P577
2001-05-01T00:00:00Z